NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,269 | -43.1% | 19,588 | -20.6% | 0.00% | – |
| Q2 2023 | $44,388 | +21.6% | 24,660 | 0.0% | 0.00% | – |
| Q1 2023 | $36,497 | +5.0% | 24,660 | 0.0% | 0.00% | – |
| Q4 2022 | $34,771 | -48.9% | 24,660 | 0.0% | 0.00% | – |
| Q3 2022 | $68,000 | -40.4% | 24,660 | +1.6% | 0.00% | – |
| Q2 2022 | $114,000 | -34.5% | 24,283 | -32.4% | 0.00% | – |
| Q1 2022 | $174,000 | -18.3% | 35,900 | +1.1% | 0.00% | – |
| Q4 2021 | $213,000 | – | 35,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |